A citation-based method for searching scientific literature

B B Koolen, T S Aukema, A J González Martínez, W V Vogel, L Caballero Ontanaya, M J Vrancken Peeters, C J J Vroonland, E J Rutgers, J M Benlloch Baviera, R A Valdés Olmos. Q J Nucl Med Mol Imaging 2013
Times Cited: 14







List of co-cited articles
63 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Breast imaging with positron emission tomography and fluorine-18 fluorodeoxyglucose: use and limitations.
N Avril, C A Rosé, M Schelling, J Dose, W Kuhn, S Bense, W Weber, S Ziegler, H Graeff, M Schwaiger. J Clin Oncol 2000
353
50

PET-guided breast biopsy.
Judith E Kalinyak, Kathy Schilling, Wendie A Berg, Deepa Narayanan, Jennifer P Mayberry, Rajesh Rai, Elizabeth B Dupree, Denise K Shusterman, Mark A Gittleman, Weidong Luo,[...]. Breast J 2011
39
42

Imaging sensitivity of dedicated positron emission mammography in relation to tumor size.
Jae Seon Eo, In Kook Chun, Jin Chul Paeng, Keon Wook Kang, Sang Mi Lee, Wonshik Han, Dong-Young Noh, June-Key Chung, Dong Soo Lee. Breast 2012
44
35

Breast cancer: comparative effectiveness of positron emission mammography and MR imaging in presurgical planning for the ipsilateral breast.
Wendie A Berg, Kathleen S Madsen, Kathy Schilling, Marie Tartar, Etta D Pisano, Linda Hovanessian Larsen, Deepa Narayanan, Al Ozonoff, Joel P Miller, Judith E Kalinyak. Radiology 2011
100
35

Evaluation of a Hanging-Breast PET System for Primary Tumor Visualization in Patients With Stage I-III Breast Cancer: Comparison With Standard PET/CT.
Suzana C Teixeira, José Ferrér Rebolleda, Bas B Koolen, Jelle Wesseling, Raúl Sánchez Jurado, Marcel P M Stokkel, María Del Puig Cózar Santiago, Vincent van der Noort, Emiel J Th Rutgers, Renato A Valdés Olmos. AJR Am J Roentgenol 2016
20
35

[Added value of prone position technique for PET-TAC in breast cancer patients].
S Vidal-Sicart, T S Aukema, W V Vogel, C A Hoefnagel, R A Valdés-Olmos. Rev Esp Med Nucl 2010
23
28

Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET.
B B Koolen, W V Vogel, M J T F D Vrancken Peeters, C E Loo, E J Th Rutgers, R A Valdés Olmos. J Oncol 2012
30
28

Clinical imaging characteristics of the positron emission mammography camera: PEM Flex Solo II.
Lawrence MacDonald, John Edwards, Thomas Lewellen, David Haseley, James Rogers, Paul Kinahan. J Nucl Med 2009
88
21

Intratumor heterogeneity and branched evolution revealed by multiregion sequencing.
Marco Gerlinger, Andrew J Rowan, Stuart Horswell, M Math, James Larkin, David Endesfelder, Eva Gronroos, Pierre Martinez, Nicholas Matthews, Aengus Stewart,[...]. N Engl J Med 2012
21

Is there a role for positron emission tomography in breast cancer staging?
Nicole C Hodgson, Karen Y Gulenchyn. J Clin Oncol 2008
81
21

Quantitative assessment of heterogeneity in tumor metabolism using FDG-PET.
Dennis Vriens, Jonathan A Disselhorst, Wim J G Oyen, Lioe-Fee de Geus-Oei, Eric P Visser. Int J Radiat Oncol Biol Phys 2012
30
21

Comparative effectiveness of positron emission mammography and MRI in the contralateral breast of women with newly diagnosed breast cancer.
Wendie A Berg, Kathleen S Madsen, Kathy Schilling, Marie Tartar, Etta D Pisano, Linda Hovanessian Larsen, Deepa Narayanan, Judith E Kalinyak. AJR Am J Roentgenol 2012
35
21

Initial characterization of a dedicated breast PET/CT scanner during human imaging.
Spencer L Bowen, Yibao Wu, Abhijit J Chaudhari, Lin Fu, Nathan J Packard, George W Burkett, Kai Yang, Karen K Lindfors, David K Shelton, Rosalie Hagge,[...]. J Nucl Med 2009
68
21

18F-FDG PET/CT as a staging procedure in primary stage II and III breast cancer: comparison with conventional imaging techniques.
Bas B Koolen, Marie-Jeanne T F D Vrancken Peeters, Tjeerd S Aukema, Wouter V Vogel, Hester S A Oldenburg, Jos A van der Hage, Cornelis A Hoefnagel, Marcel P M Stokkel, Claudette E Loo, Sjoerd Rodenhuis,[...]. Breast Cancer Res Treat 2012
86
21

Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.
Wendie A Berg, Lorena Gutierrez, Moriel S NessAiver, W Bradford Carter, Mythreyi Bhargavan, Rebecca S Lewis, Olga B Ioffe. Radiology 2004
869
21

Positron emission mammography in breast cancer presurgical planning: comparisons with magnetic resonance imaging.
Kathy Schilling, Deepa Narayanan, Judith E Kalinyak, Juliette The, Maria Victoria Velasquez, Simone Kahn, Matthew Saady, Ravinder Mahal, Larraine Chrystal. Eur J Nucl Med Mol Imaging 2011
62
21

Positron emission mammography: correlation of estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status and 18F-FDG.
Carolyn L Wang, Lawrence R MacDonald, James V Rogers, Aleksandr Aravkin, David R Haseley, J David Beatty. AJR Am J Roentgenol 2011
46
21

Impact of FDG PET on the preoperative staging of newly diagnosed breast cancer.
Tevfik F Cermik, Ayse Mavi, Sandip Basu, Abass Alavi. Eur J Nucl Med Mol Imaging 2008
71
21


Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.
N Avril, M Menzel, J Dose, M Schelling, W Weber, F Jänicke, W Nathrath, M Schwaiger. J Nucl Med 2001
302
21


Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts.
Deborah J Rhodes, Carrie B Hruska, Amy Lynn Conners, Cindy L Tortorelli, Robert W Maxwell, Katie N Jones, Alicia Y Toledano, Michael K O'Connor. AJR Am J Roentgenol 2015
87
21

Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT.
Judith E Kalinyak, Wendie A Berg, Kathy Schilling, Kathleen S Madsen, Deepa Narayanan, Marie Tartar. Eur J Nucl Med Mol Imaging 2014
54
21

Association between [18F]fluorodeoxyglucose uptake and prognostic parameters in breast cancer.
A Gil-Rendo, F Martínez-Regueira, G Zornoza, M J García-Velloso, C Beorlegui, N Rodriguez-Spiteri. Br J Surg 2009
117
14


High-resolution fluorodeoxyglucose positron emission tomography with compression ("positron emission mammography") is highly accurate in depicting primary breast cancer.
Wendie A Berg, Irving N Weinberg, Deepa Narayanan, Mary E Lobrano, Eric Ross, Laura Amodei, Lorraine Tafra, Lee P Adler, Joseph Uddo, William Stein,[...]. Breast J 2006
140
14

PET characteristics of a dedicated breast PET/CT scanner prototype.
Yibao Wu, Spencer L Bowen, Kai Yang, Nathan Packard, Lin Fu, George Burkett, Jinyi Qi, John M Boone, Simon R Cherry, Ramsey D Badawi. Phys Med Biol 2009
31
14

Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast.
Michael K O'Connor, Hua Li, Deborah J Rhodes, Carrie B Hruska, Conor B Clancy, Richard J Vetter. Med Phys 2010
37
14

Intratumor heterogeneity: seeing the wood for the trees.
Timothy A Yap, Marco Gerlinger, P Andrew Futreal, Lajos Pusztai, Charles Swanton. Sci Transl Med 2012
357
14

Recommendations on the use of 18F-FDG PET in oncology.
James W Fletcher, Benjamin Djulbegovic, Heloisa P Soares, Barry A Siegel, Val J Lowe, Gary H Lyman, R Edward Coleman, Richard Wahl, John Christopher Paschold, Norbert Avril,[...]. J Nucl Med 2008
676
14

Initial clinical test of a breast-PET scanner.
Raymond R Raylman, Jame Abraham, Hannah Hazard, Courtney Koren, Shannon Filburn, Judith S Schreiman, Sobha Kurian, Stan Majewski, Gary D Marano. J Med Imaging Radiat Oncol 2011
15
14

Preoperative staging of large primary breast cancer with [18F]fluorodeoxyglucose positron emission tomography/computed tomography compared with conventional imaging procedures.
David Fuster, Joan Duch, Pilar Paredes, Martín Velasco, Montserrat Muñoz, Gorane Santamaría, Montserrat Fontanillas, Francesca Pons. J Clin Oncol 2008
188
14

The positron emission mammography/tomography breast imaging and biopsy system (PEM/PET): design, construction and phantom-based measurements.
Raymond R Raylman, Stan Majewski, Mark F Smith, James Proffitt, William Hammond, Amarnath Srinivasan, John McKisson, Vladimir Popov, Andrew Weisenberger, Clifford O Judy,[...]. Phys Med Biol 2008
68
14


Detection of extra-axillary lymph node involvement with FDG PET/CT in patients with stage II-III breast cancer.
Tjeerd S Aukema, Marieke E Straver, Marie-Jeanne T F D Vrancken Peeters, Nicola S Russell, Kenneth G A Gilhuijs, Wouter V Vogel, Emiel J T Rutgers, Renato A Valdés Olmos. Eur J Cancer 2010
67
14

Cancer statistics, 2012.
Rebecca Siegel, Deepa Naishadham, Ahmedin Jemal. CA Cancer J Clin 2012
14


Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer.
David Groheux, Sylvie Giacchetti, Jean-Luc Moretti, Raphael Porcher, Marc Espié, Jacqueline Lehmann-Che, Anne de Roquancourt, Anne-Sophie Hamy, Caroline Cuvier, Laetitia Vercellino,[...]. Eur J Nucl Med Mol Imaging 2011
246
14

The role of FDG PET/CT in patients with locoregional breast cancer recurrence: a comparison to conventional imaging techniques.
T S Aukema, E J Th Rutgers, W V Vogel, H J Teertstra, H S Oldenburg, M T F D Vrancken Peeters, J Wesseling, N S Russell, R A Valdés Olmos. Eur J Surg Oncol 2010
60
14

Molecular analysis reveals a genetic basis for the phenotypic diversity of metaplastic breast carcinomas.
Felipe C Geyer, Britta Weigelt, Rachael Natrajan, Maryou B K Lambros, Dario de Biase, Radost Vatcheva, Kay Savage, Alan Mackay, Alan Ashworth, Jorge S Reis-Filho. J Pathol 2010
140
14

Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy.
Bas B Koolen, Renato A Valdés Olmos, Paula H M Elkhuizen, Wouter V Vogel, Marie-Jeanne T F D Vrancken Peeters, Sjoerd Rodenhuis, Emiel J Th Rutgers. Breast Cancer Res Treat 2012
42
14

Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype.
Claudette E Loo, Marieke E Straver, Sjoerd Rodenhuis, Sara H Muller, Jelle Wesseling, Marie-Jeanne T F D Vrancken Peeters, Kenneth G A Gilhuijs. J Clin Oncol 2011
183
14

Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy.
B B Koolen, M J T F D Vrancken Peeters, J Wesseling, E H Lips, W V Vogel, T S Aukema, E van Werkhoven, K G A Gilhuijs, S Rodenhuis, E J Th Rutgers,[...]. Eur J Nucl Med Mol Imaging 2012
64
14

Diagnostic architectural and dynamic features at breast MR imaging: multicenter study.
Mitchell D Schnall, Jeffrey Blume, David A Bluemke, Gia A DeAngelis, Nanette DeBruhl, Steven Harms, Sylvia H Heywang-Köbrunner, Nola Hylton, Christiane K Kuhl, Etta D Pisano,[...]. Radiology 2006
320
14



Clinical performance of 2 dedicated PET scanners for breast imaging: initial evaluation.
Mami Iima, Yuji Nakamoto, Shotaro Kanao, Tomoharu Sugie, Takayuki Ueno, Mayumi Kawada, Yoshiki Mikami, Masakazu Toi, Kaori Togashi. J Nucl Med 2012
29
14

Diagnostic workup and costs of a single supplemental molecular breast imaging screen of mammographically dense breasts.
Carrie B Hruska, Amy Lynn Conners, Katie N Jones, Michael K O'Connor, James P Moriarty, Judy C Boughey, Deborah J Rhodes. AJR Am J Roentgenol 2015
23
14

Dual-modality breast tomosynthesis.
Mark B Williams, Patricia G Judy, Spencer Gunn, Stanislaw Majewski. Radiology 2010
27
14

Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors.
Carrie B Hruska, Stephen W Phillips, Dana H Whaley, Deborah J Rhodes, Michael K O'Connor. AJR Am J Roentgenol 2008
70
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.